Scoping review of interventions to de-implement potentially harmful non-steroidal anti-inflammatory drugs (NSAIDs) in healthcare settings
- PMID: 38631836
- PMCID: PMC11029194
- DOI: 10.1136/bmjopen-2023-078808
Scoping review of interventions to de-implement potentially harmful non-steroidal anti-inflammatory drugs (NSAIDs) in healthcare settings
Abstract
Objectives: Potentially harmful non-steroidal anti-inflammatory drugs (NSAIDs) utilisation persists at undesirable rates worldwide. The purpose of this paper is to review the literature on interventions to de-implement potentially harmful NSAIDs in healthcare settings and to suggest directions for future research.
Design: Scoping review.
Data sources: PubMed, CINAHL, Embase, Cochrane Central and Google Scholar (1 January 2000 to 31 May 2022).
Study selection: Studies reporting on the effectiveness of interventions to systematically reduce potentially harmful NSAID utilisation in healthcare settings.
Data extraction: Using Covidence systematic review software, we extracted study and intervention characteristics, including the effectiveness of interventions in reducing NSAID utilisation.
Results: From 7818 articles initially identified, 68 were included in the review. Most studies took place in European countries (45.6%) or the USA (35.3%), with randomised controlled trial as the most common design (55.9%). Interventions were largely clinician-facing (76.2%) and delivered in primary care (60.2%) but were rarely (14.9%) guided by an implementation model, framework or theory. Academic detailing, clinical decision support or electronic medical record interventions, performance reports and pharmacist review were frequent approaches employed. NSAID use was most commonly classified as potentially harmful based on patients' age (55.8%), history of gastrointestinal disorders (47.1%), or history of kidney disease (38.2%). Only 7.4% of interventions focused on over-the-counter (OTC) NSAIDs in addition to prescription. The majority of studies (76.2%) reported a reduction in the utilisation of potentially harmful NSAIDs. Few studies (5.9%) evaluated pain or quality of life following NSAIDs discontinuation.
Conclusion: Many varied interventions to de-implement potentially harmful NSAIDs have been applied in healthcare settings worldwide. Based on these findings and identified knowledge gaps, further efforts to comprehensively evaluate the effectiveness of interventions and the combination of intervention characteristics associated with effective de-implementation are needed. In addition, future work should be guided by de-implementation theory, focus on OTC NSAIDs and incorporate patient-focused strategies and outcomes, including the evaluation of unintended consequences of the intervention.
Keywords: Cardiovascular Disease; Chronic Pain; GERIATRIC MEDICINE; Health & safety; Primary Care; Quality in health care.
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Update of
-
A Scoping Review of Interventions to De-implement Potentially Harmful Nonsteroidal Anti-inflammatory Drugs (NSAIDs) in Healthcare Settings.medRxiv [Preprint]. 2023 Jul 30:2023.07.29.23293362. doi: 10.1101/2023.07.29.23293362. medRxiv. 2023. Update in: BMJ Open. 2024 Apr 17;14(4):e078808. doi: 10.1136/bmjopen-2023-078808. PMID: 37546911 Free PMC article. Updated. Preprint.
Similar articles
-
A Scoping Review of Interventions to De-implement Potentially Harmful Nonsteroidal Anti-inflammatory Drugs (NSAIDs) in Healthcare Settings.medRxiv [Preprint]. 2023 Jul 30:2023.07.29.23293362. doi: 10.1101/2023.07.29.23293362. medRxiv. 2023. Update in: BMJ Open. 2024 Apr 17;14(4):e078808. doi: 10.1136/bmjopen-2023-078808. PMID: 37546911 Free PMC article. Updated. Preprint.
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Non-steroidal anti-inflammatory drugs for acute low back pain.Cochrane Database Syst Rev. 2020 Apr 16;4(4):CD013581. doi: 10.1002/14651858.CD013581. Cochrane Database Syst Rev. 2020. PMID: 32297973 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia.Cochrane Database Syst Rev. 2020 Apr 30;4(4):CD011459. doi: 10.1002/14651858.CD011459.pub2. Cochrane Database Syst Rev. 2020. PMID: 32352165 Free PMC article.
References
-
- Jahnavi K, Pavani Reddy P, Vasudha B, et al. . Non-steroidal anti-inflammatory drugs: an overview. J Drug Delivery Ther 2019;9:442–8. 10.22270/jddt.v9i1-s.2287 - DOI
-
- Ghlichloo I, Gerriets V. Nonsteroidal anti-inflammatory drugs (NSAIDs). In: StatPearls. StatPearls Publishing, 2023. Available: http://www.ncbi.nlm.nih.gov/books/NBK547742/ - PubMed
-
- CDC surveillance system: percentage of prescribed NSAID use among U.S. adults. Available: https://nccd.cdc.gov/ckd/detail.aspx?Qnum=Q700 [Accessed 04 May 2023].
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources